Page last updated: 2024-08-23

epirubicin and Urinary Retention

epirubicin has been researched along with Urinary Retention in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cheng, K; Duan, F; Feng, DP; Fu, JX; Wang, MQ; Xin, H; Ye, HY; Yu, HK; Yuan, B; Zhang, JL; Zhang, XJ	1

Other Studies

1 other study(ies) available for epirubicin and Urinary Retention

Article	Year
Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer. Prostate cancer and prostatic diseases, 2023, Volume: 26, Issue:1 Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Docetaxel; Epirubicin; Hematuria; Humans; Liver Neoplasms; Male; Middle Aged; Prostate; Prostatic Neoplasms; Quality of Life; Treatment Outcome; Urinary Retention	2023

Article

Year

Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer.

Prostate cancer and prostatic diseases, 2023, Volume: 26, Issue:1

Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Docetaxel; Epirubicin; Hematuria; Humans; Liver Neoplasms; Male; Middle Aged; Prostate; Prostatic Neoplasms; Quality of Life; Treatment Outcome; Urinary Retention

2023